Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the a
Calyxt, Inc. (NASDAQ:CLXT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Operator Good afternoon, ladies and
Upgrades Citigroup upgraded the previous rating for Advanced Energy Industries Inc (NASDAQ:AEIS) from Neutral to Buy. For the third quarter, Advanced Energy Indus had an EPS of $2.12, compared to yea
Calyxt (CLXT) delivered earnings and revenue surprises of 13.33% and 86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Bears are Losing Control Over Calyxt (CLXT), Here's Why It's a 'Buy' Now

01:55pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
Calyxt (CLXT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tren
Gainers Software Acquisition Group Inc. III (NASDAQ: NOGN) shares rose 80.1% to $6.04 in pre-market trading after dropping over 65% on Tuesday. Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares rose 3
Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer

Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates

10:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Calyxt (CLXT) delivered earnings and revenue surprises of 6.67% and 36.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ --   Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:3
Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share. SKYX Platforms Corp. (NASDAQ: SKYX) jumped
Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Con

Calyxt (CLXT) Reports Q1 Loss, Misses Revenue Estimates

09:45pm, Thursday, 05'th May 2022 Zacks Investment Research
Calyxt (CLXT) delivered earnings and revenue surprises of 22.22% and 96.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.
Calyxt is now on to its third business plan, pivoting from gene-edited seed traits to synthetic biology. The company is looking to produce molecules of interest to pharmaceutical, nutraceutical, and c
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE